HomeAI · summaries
Storia in 4 fonti
Novo Nordisk and Eli Lilly fall after Hims & Hers announce $49 copy of Wegovy pill
Novo Nordisk and Eli Lilly fell after Hims & Hers said it will offer a copy of the Wegovy pill for $49, far less than the $149 Novo sells the branded pill for.
Confronto fonti
4 prospettive sulla stessa storiaTimeline cronologica
- ·
cnbc.com
Novo Nordisk and Eli Lilly fall after Hims & Hers announce $49 copy of Wegovy pill
Novo Nordisk and Eli Lilly fell after Hims & Hers said it will offer a copy of the Wegovy pill for $49, far less than the $149 Novo sells the branded pill for.
- ·
cincodias.elpais.com
La empresa de telesalud Hims planta cara a Novo Nordisk con su propia versión del Wegovy por 49 dólares al mes, un tercio del precio de su…
La pastilla de administración diaria contiene el mismo principio activo que el medicamento estrella de la farmacéutica danesa
- ·
ft.com
Novo Nordisk hits out at rival Hims & Hers over cheaper weight-loss pill
US telehealth group will sell product for $49 a month, a third that of its Danish competitor
- ·
Hims & Hers falls 8% after Novo's legal threat. Here's the latest
Hims & Hers stock fall to a 12-month low after Novo said it's $49 Wegovy pill copy was "illegal"
- ·
US signals crackdown on compounded weight-loss drugs; Hims shares tumble
The FDA said on Friday it plans to restrict GLP-1 ingredients used in non-approved compounded drugs from companies like Hims & Hers.
- ·
Hims & Hers abandons copycat weight-loss drug in face of FDA probe
Novo Nordisk had accused the telehealth company of breaching its patent on Wegovy
- ·
Hims & Hers pulls copycat weight-loss pill after threats of legal action
Hims & Hers on Saturday announced it would stop offering its copycat of the weight-loss pill Wegovy after threats of legal action.
- ·
fortune.com
Hims & Hers scraps copycat Wegovy weight-loss pill after probe | Fortune
The announcement comes a day after the US Food and Drug Administration said it was cracking down on copycat weight-loss treatments.